Retatrutide 15 mg Historical COAs

This page contains historical Certificates of Analysis for Integrity Peptides Retatrutide 15 mg.

Previous batch records are retained here as newer batches replace them, allowing customers to verify earlier purchases and review the testing history for Retatrutide 15 mg.

Historical Certificates of Analysis

Batch RT15-013

Lot number: RT15-013
Purity: 99.86%
Measured amount: 17.27 mg
Appearance: White lyophilized powder
Cap colour: Clear
Laboratory: Testides
Sample received: May 29, 2026
Tested: June 5, 2026
Reported: June 8, 2026
Testing completed: HPLC and endotoxin testing
Endotoxin result: Less than 0.125 EU/mL
Endotoxin method: Kinetic LAL, USP <85>
Endotoxin interpretation: Endotoxin was not detected at the laboratory’s reporting threshold of 0.125 EU/mL, using a validated 1:16 dilution of a 3.0 mL reconstituted vial.
Status: Historical batch

View Batch RT15-013 Certificate of Analysis

Verify Batch RT15-013 Through Testides

Batch IP-RETA-012

Lot number: IP-RETA-012
Purity: 99.91%
Measured amount: 17.00 mg
Appearance: White lyophilized powder
Laboratory: Testides
Sample received: January 22, 2026
Tested: January 27, 2026
Reported: January 28, 2026
Testing completed: HPLC
Status: Historical batch

View Batch IP-RETA-012 Certificate of Analysis

Verify Batch IP-RETA-012 Through Testides

Current Testing

View Current Retatrutide 15 mg Testing & COA

Product Page

View Retatrutide 15 mg

Important Information

Certificates of Analysis apply only to the specific product and batch number identified on the report.

Always confirm that the batch or lot number shown on your product matches the identifying information listed on the corresponding Certificate of Analysis.